CYP11B2 and Hypertension resistant to conventional therapy: Our findings in the Japanese population, in combination with previous genetic and clinical findings, suggest that the aldosterone synthase gene (CYP11B2) may be a potential causal gene for resistant hypertension, and support the important role of aldosterone and its pathways in the pathophysiology of resistant hypertension, the same as for hypertension.